Walmart's slowest US comparable sales in five years knock the shares
Cheaper prescription drugs and more cautious shoppers held second-quarter US comparable sales growth to 2.6%.
Walmart reported 2.6% growth in US comparable sales for its second quarter, its weakest in over five years, and the shares fell on the 20 August session.